SIC 2833 – Medicinal Chemicals and Botanical Products
Valuation | |
---|---|
Market Cap ($M) | 8.74 |
Enterprise Value ($M) | 35.04 |
Book Value ($M) | 25.46 |
Book Value / Share | 1.22 |
Price / Book | 0.34 |
NCAV ($M) | -14.11 |
NCAV / Share | -0.68 |
Price / NCAV | -0.62 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.37 |
Return on Assets (ROA) | -0.28 |
Return on Equity (ROE) | -0.57 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.33 |
Current Ratio | 0.93 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 22.58 |
Assets | 62.16 |
Liabilities | 36.70 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Hackett Robert | 8.50 | 5.90 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q/A Amendment No. 1 | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
14,785 | 31,006 | 47.68 | |
3,051 | 24,854 | 12.28 | |
8,248 | 20,503 | 40.23 | |
20,871 | 4,851 | 430.24 | |
39,984 | 75,471 | 52.98 | |
(click for more detail) |
Similar Companies | |
---|---|
TTNP – Titan Pharmaceuticals, Inc. | UNCY – Unicycive Therapeutics, Inc. |
UPC – Universe Pharmaceuticals INC | VBIV – VBI Vaccines Inc. |
VCNX – Vaccinex, Inc. |
Financial data and stock pages provided by
Fintel.io